Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study.

Falck AK, Bendahl PO, Ingvar C, Isola J, Jönsson PE, Lindblom P, Lövgren K, Rennstam K, Fernö M, Rydén L.

BMC Cancer. 2012 Sep 11;12:403. doi: 10.1186/1471-2407-12-403.

2.

FACT: an open-label randomized phase III study of fulvestrant and anastrozole in combination compared with anastrozole alone as first-line therapy for patients with receptor-positive postmenopausal breast cancer.

Bergh J, Jönsson PE, Lidbrink EK, Trudeau M, Eiermann W, Brattström D, Lindemann JP, Wiklund F, Henriksson R.

J Clin Oncol. 2012 Jun 1;30(16):1919-25. doi: 10.1200/JCO.2011.38.1095. Epub 2012 Feb 27.

PMID:
22370325
3.

Axillary recurrence rate 5 years after negative sentinel node biopsy for breast cancer.

Andersson Y, de Boniface J, Jönsson PE, Ingvar C, Liljegren G, Bergkvist L, Frisell J; Swedish Breast Cancer Group; Swedish Society of Breast Surgeons.

Br J Surg. 2012 Feb;99(2):226-31. doi: 10.1002/bjs.7820. Epub 2011 Dec 19.

PMID:
22180063
4.

p27Kip1 is a predictive factor for tamoxifen treatment response but not a prognostic marker in premenopausal breast cancer patients.

Stendahl M, Nilsson S, Wigerup C, Jirström K, Jönsson PE, Stål O, Landberg G.

Int J Cancer. 2010 Dec 15;127(12):2851-8. doi: 10.1002/ijc.25297.

5.

Effects of interparticle interaction in ferromagnetic nanoparticle systems.

Jönsson PE.

J Nanosci Nanotechnol. 2010 Sep;10(9):6067-71.

PMID:
21133150
6.

Natural remedy use in a prospective cohort of breast cancer patients in southern Sweden.

Hietala M, Henningson M, Ingvar C, Jönsson PE, Rose C, Jernström H.

Acta Oncol. 2011 Jan;50(1):134-43. doi: 10.3109/0284186X.2010.484812. Epub 2010 May 25.

PMID:
20500030
7.

Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wall.

Styring E, Fernebro J, Jönsson PE, Ehinger A, Engellau J, Rissler P, Rydholm A, Nilbert M, Vult von Steyern F.

Breast Cancer Res Treat. 2010 Aug;122(3):883-7. doi: 10.1007/s10549-009-0703-8. Epub 2010 Jan 20.

PMID:
20087653
8.

17ss-Hydroxysteroid dehydrogenase type 1 as predictor of tamoxifen response in premenopausal breast cancer.

Källström AC, Salme R, Rydén L, Nordenskjöld B, Jönsson PE, Stål O.

Eur J Cancer. 2010 Mar;46(5):892-900. doi: 10.1016/j.ejca.2009.12.016. Epub 2010 Jan 8.

PMID:
20060711
9.

CYP2C8 and CYP2C9 polymorphisms in relation to tumour characteristics and early breast cancer related events among 652 breast cancer patients.

Jernström H, Bågeman E, Rose C, Jönsson PE, Ingvar C.

Br J Cancer. 2009 Dec 1;101(11):1817-23. doi: 10.1038/sj.bjc.6605428.

10.

Evidence for tissue factor phosphorylation and its correlation with protease-activated receptor expression and the prognosis of primary breast cancer.

Rydén L, Grabau D, Schaffner F, Jönsson PE, Ruf W, Belting M.

Int J Cancer. 2010 May 15;126(10):2330-40. doi: 10.1002/ijc.24921.

11.

Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish Multicenter Cohort Study.

Bergkvist L, de Boniface J, Jönsson PE, Ingvar C, Liljegren G, Frisell J; Swedish Society of Breast Surgeons.

Ann Surg. 2008 Jan;247(1):150-6.

PMID:
18156935
12.

Sentinel lymph node biopsy in operations for recurrent breast cancer.

Axelsson CK, Jønsson PE.

Eur J Surg Oncol. 2008 Jun;34(6):626-30. Epub 2007 Oct 29.

PMID:
18029134
13.

Correlation-driven heavy-fermion formation in LiV2O4.

Jönsson PE, Takenaka K, Niitaka S, Sasagawa T, Sugai S, Takagi H.

Phys Rev Lett. 2007 Oct 19;99(16):167402. Epub 2007 Oct 19.

PMID:
17995290
14.

Absence of conventional spin-glass transition in the Ising dipolar system LiHo(x)Y(1-x)F(4).

Jönsson PE, Mathieu R, Wernsdorfer W, Tkachuk AM, Barbara B.

Phys Rev Lett. 2007 Jun 22;98(25):256403. Epub 2007 Jun 21.

PMID:
17678041
16.

High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients.

Stendahl M, Rydén L, Nordenskjöld B, Jönsson PE, Landberg G, Jirström K.

Clin Cancer Res. 2006 Aug 1;12(15):4614-8.

17.

Pathology parameters and adjuvant tamoxifen response in a randomised premenopausal breast cancer trial.

Jirström K, Rydén L, Anagnostaki L, Nordenskjöld B, Stål O, Thorstenson S, Chebil G, Jönsson PE, Fernö M, Landberg G.

J Clin Pathol. 2005 Nov;58(11):1135-42.

18.
19.

Preoperative assessment of small tumours in women with breast cancer.

Kald BA, Boiesen P, Ronnow K, Jonsson PE, Bisgaard T.

Scand J Surg. 2005;94(1):15-20.

PMID:
15865110
20.

Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: a randomised, controlled trial with long-term follow-up.

Rydén L, Jönsson PE, Chebil G, Dufmats M, Fernö M, Jirström K, Källström AC, Landberg G, Stål O, Thorstenson S, Nordenskjöld B; South Swedish Breast Cancer Group; South-East Swedish Breast Cancer Group.

Eur J Cancer. 2005 Jan;41(2):256-64.

PMID:
15661551
21.

Comment on "memory effects in an interacting magnetic nanoparticle system".

Sasaki M, Jönsson PE, Takayama H, Nordblad P.

Phys Rev Lett. 2004 Sep 24;93(13):139701, author reply 139703. Epub 2004 Sep 21. No abstract available.

PMID:
15524767
22.

Hospital stay related to TNM-stage and the surgical procedure in primary breast cancer.

Lindqvist R, Alvegard TA, Jönsson PE, Stenbeck M.

Acta Oncol. 2004;43(6):545-50.

PMID:
15370611
23.

Assessment of microvessel density in core needle biopsy specimen in breast cancer.

Rydén L, Boiesen P, Jönsson PE.

Anticancer Res. 2004 Jan-Feb;24(1):371-5.

24.

Tumor specific VEGF-A and VEGFR2/KDR protein are co-expressed in breast cancer.

Rydén L, Linderholm B, Nielsen NH, Emdin S, Jönsson PE, Landberg G.

Breast Cancer Res Treat. 2003 Dec;82(3):147-54.

PMID:
14703061
25.

Decreased angiogenic activity in breast cancer in ever-users of oral contraceptive therapy--preliminary report.

Rydén L, Boiesen P, Jönsson PE.

Anticancer Res. 2003 May-Jun;23(3C):2875-8.

PMID:
12926126
26.

Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening.

Malmström P, Holmberg L, Anderson H, Mattsson J, Jönsson PE, Tennvall-Nittby L, Balldin G, Lovén L, Svensson JH, Ingvar C, Möller T, Holmberg E, Wallgren A; Swedisj Breast Cancer Group.

Eur J Cancer. 2003 Aug;39(12):1690-7.

PMID:
12888363
27.

Small bowel obstruction caused by intestinal metastases from undiagnosed breast cancer: report of two cases.

Rydén L, Chebil G, Jönsson PE.

Eur J Surg. 2002;168(11):648-50. No abstract available.

PMID:
12699105
28.

Symmetrical temperature-chaos effect with positive and negative temperature shifts in a spin glass.

Jönsson PE, Yoshino H, Nordblad P.

Phys Rev Lett. 2002 Aug 26;89(9):097201. Epub 2002 Aug 8.

PMID:
12190431
29.

Domain growth by isothermal aging in 3D Ising and Heisenberg spin glasses.

Jönsson PE, Yoshino H, Nordblad P, Aruga Katori H, Ito A.

Phys Rev Lett. 2002 Jun 24;88(25 Pt 1):257204. Epub 2002 Jun 10.

PMID:
12097126
30.

A systematic overview of chemotherapy effects in breast cancer.

Bergh J, Jönsson PE, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):253-81. Review.

PMID:
11441936
31.

The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of chemotherapy effects in some major tumour types--summary and conclusions.

Glimelius B, Bergh J, Brandt L, Brorsson B, Gunnars B, Hafström L, Haglund U, Högberg T, Janunger KG, Jönsson PE, Karlsson G, Kimby E, Lamnevik G, Nilsson S, Permert J, Ragnhammar P, Sörenson S, Nygren P.

Acta Oncol. 2001;40(2-3):135-54. Review.

PMID:
11441927
32.

A pharmacokinetic study of 5-FU/leucovorin and alpha-interferon in advanced cancer.

Larsson PA, Glimelius B, Jeppsson B, Jönsson PE, Malmberg M, Gustavsson B, Carlsson G, Svedberg M.

Acta Oncol. 2000;39(1):59-63.

PMID:
10752655
33.

Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm.

Cohn-Cedermark G, Rutqvist LE, Andersson R, Breivald M, Ingvar C, Johansson H, Jönsson PE, Krysander L, Lindholm C, Ringborg U.

Cancer. 2000 Oct 1;89(7):1495-501.

PMID:
11013363
34.

Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with a tumor thickness of 0.8 to 2.0 mm: randomized study by the Swedish Melanoma Study Group.

Ringborg U, Andersson R, Eldh J, Glaumann B, Hafström L, Jacobsson S, Jönsson PE, Johansson H, Krysander L, Lagerlöf B.

Cancer. 1996 May 1;77(9):1809-14.

PMID:
8646678
35.

Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factors.

Olsson H, Jernström H, Alm P, Kreipe H, Ingvar C, Jönsson PE, Rydén S.

Breast Cancer Res Treat. 1996;40(2):187-96.

PMID:
8879685
36.

Treatment of liver metastases from colorectal cancer with hepatic artery occlusion, intraportal 5-fluorouracil infusion, and oral allopurinol. A randomized clinical trial.

Hafström L, Engarås B, Holmberg SB, Gustavsson B, Jönsson PE, Lindnér P, Naredi P, Tidebrant G.

Cancer. 1994 Nov 15;74(10):2749-56. Erratum in: Cancer 1995 Mar 1;75(5):1218.

PMID:
7954233
37.

Use of sunbeds or sunlamps and malignant melanoma in southern Sweden.

Westerdahl J, Olsson H, Måsbäck A, Ingvar C, Jonsson N, Brandt L, Jönsson PE, Möller T.

Am J Epidemiol. 1994 Oct 15;140(8):691-9.

PMID:
7942771
38.

Heterogeneous distribution of radiolabelled monoclonal antibody. Autoradiographic evaluation in the nude rat model.

Ingvar C, Norrgren K, Strand SE, Jönsson PE.

Anticancer Res. 1994 Jan-Feb;14(1A):141-6.

PMID:
8166441
39.

Southern travelling habits with special reference to tumour site in Swedish melanoma patients.

Westerdahl J, Olsson H, Ingvar C, Brandt L, Jönsson PE, Möller T.

Anticancer Res. 1992 Sep-Oct;12(5):1539-42.

PMID:
1444218
41.

Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. Swedish Melanoma Study Group.

Hafström L, Rudenstam CM, Blomquist E, Ingvar C, Jönsson PE, Lagerlöf B, Lindholm C, Ringborg U, Westman G, Ostrup L.

J Clin Oncol. 1991 Dec;9(12):2091-4.

PMID:
1960549
42.

[Puncture biopsies must not be abused].

Beitner H, Jacobsson S, Jönsson PE, Lagerlöf B.

Lakartidningen. 1991 Oct 2;88(40):3262. Swedish. No abstract available.

PMID:
1943335
43.

Weekly dose adriamycin as first line chemotherapy in advanced breast cancer.

Jönsson PE, Malmberg M, Ericsson M, Ryden S.

Anticancer Res. 1991 Mar-Apr;11(2):877-9.

PMID:
2064346
44.

Phase II study of high dose toremifene in advanced breast cancer progressing during tamoxifene treatment.

Jönsson PE, Malmberg M, Bergljung L, Ingvar C, Ericsson M, Ryden S, Nilsson I, Terje IJ.

Anticancer Res. 1991 Mar-Apr;11(2):873-5.

PMID:
1829600
45.

Tumour uptake of monoclonal antibody after regional intraarterial injection. Biokinetics in the nude rat heterotransplanted with malignant melanoma.

Ingvar C, Norrgren K, Strand SE, Brodin T, Jönsson PE, Sjögren HO.

Acta Oncol. 1991;30(1):65-9.

PMID:
2009186
46.

Palliative surgery for brain metastases of malignant melanoma.

Oredsson S, Ingvar C, Strömblad LG, Jönsson PE.

Eur J Surg Oncol. 1990 Oct;16(5):451-6.

PMID:
1698662
47.

Tumour antigen heterogeneity within melanoma metastases--an evaluation by immunohistochemistry.

Ingvar C, Jakobsson B, Brodin T, Jönsson PE, Strand SE.

Anticancer Res. 1990 Jan-Feb;10(1):219-23.

PMID:
2334131
48.

Potentiation by dipyridamole of 5-fluorouridine antitumor activity against a rat adenocarcinoma in vivo.

el Hag IA, Roos G, Jönsson PE, Stenram U.

Anticancer Res. 1990 Jan-Feb;10(1):29-32.

PMID:
2139770
49.

Subcutaneous injection of monoclonal antibody 96.5. Biokinetics in the nude rat heterotransplanted with malignant melanoma.

Ingvar C, Norrgren K, Strand SE, Brodin T, Jönsson PE, Sjögren HO.

Acta Oncol. 1990;29(8):1047-53.

PMID:
2126179
50.

Increased plasma prolactin levels in a group of men with breast cancer--a preliminary study.

Olsson H, Alm P, Aspegren K, Gullberg B, Jönsson PE, Ranstam J.

Anticancer Res. 1990 Jan-Feb;10(1):59-62.

PMID:
2110433

Supplemental Content

Loading ...
Support Center